Literature DB >> 10935485

Somatic mutations of the PPP2R1B candidate tumor suppressor gene at chromosome 11q23 are infrequent in ovarian carcinomas.

R Wu1, D C Connolly, X Ren, E R Fearon, K R Cho.   

Abstract

Previous studies have demonstrated frequent allelic losses of distal chromosome 11q in ovarian carcinomas. The tumor suppressor gene(s) presumably targeted by these losses have not yet been identified. PPP2R1B is a candidate tumor suppressor gene at 11q23 that has recently been shown to be mutated in a subset of colorectal and lung cancers. We evaluated 5 ovarian carcinoma cell lines and 27 primary ovarian carcinomas for allelic losses of 11q23 and for mutations in the open reading frame of PPP2R1B. We also evaluated the primary tumors for allelic losses at 17p13, another chromosomal region frequently affected by losses of heterozygosity (LOH) in ovarian cancers. 11q23 and 17p13 allelic losses were identified in 25% and 74% of the carcinomas, respectively. No mutations within PPP2R1B coding sequences were found. These findings indicate that mutations of the PPP2R1B gene are infrequent in ovarian cancer and that deletions affecting the distal portion of chromosome 11q in ovarian cancer likely target inactivation of other genes.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10935485      PMCID: PMC1508096          DOI: 10.1038/sj.neo.7900042

Source DB:  PubMed          Journal:  Neoplasia        ISSN: 1476-5586            Impact factor:   5.715


  23 in total

1.  Overexpression and mutation of p53 in epithelial ovarian cancer.

Authors:  J R Marks; A M Davidoff; B J Kerns; P A Humphrey; J C Pence; R K Dodge; D L Clarke-Pearson; J D Iglehart; R C Bast; A Berchuck
Journal:  Cancer Res       Date:  1991-06-01       Impact factor: 12.701

2.  Allele losses on chromosome 17 in human epithelial ovarian carcinoma.

Authors:  D M Eccles; G Cranston; C M Steel; Y Nakamura; R C Leonard
Journal:  Oncogene       Date:  1990-10       Impact factor: 9.867

3.  p53 mutation is a common genetic event in ovarian carcinoma.

Authors:  B J Milner; L A Allan; D M Eccles; H C Kitchener; R C Leonard; K F Kelly; D E Parkin; N E Haites
Journal:  Cancer Res       Date:  1993-05-01       Impact factor: 12.701

4.  INH, a negative regulator of MPF, is a form of protein phosphatase 2A.

Authors:  T H Lee; M J Solomon; M C Mumby; M W Kirschner
Journal:  Cell       Date:  1991-01-25       Impact factor: 41.582

5.  Clonal chromosome abnormalities in 54 cases of ovarian carcinoma.

Authors:  F H Thompson; J Emerson; D Alberts; Y Liu; X Y Guan; A Burgess; S Fox; R Taetle; R Weinstein; R Makar
Journal:  Cancer Genet Cytogenet       Date:  1994-03

6.  K-ras activation occurs frequently in mucinous adenocarcinomas and rarely in other common epithelial tumors of the human ovary.

Authors:  T Enomoto; C M Weghorst; M Inoue; O Tanizawa; J M Rice
Journal:  Am J Pathol       Date:  1991-10       Impact factor: 4.307

7.  Involvement of p53 gene in the allelic deletion of chromosome 17p in human ovarian tumors.

Authors:  S W Tsao; C H Mok; K Oike; M Muto; H M Goodman; E E Sheets; R S Berkowitz; R C Knapp; C C Lau
Journal:  Anticancer Res       Date:  1991 Nov-Dec       Impact factor: 2.480

8.  Frequent loss of heterozygosity on chromosomes 6q, 11, and 17 in human ovarian carcinomas.

Authors:  J H Lee; J J Kavanagh; D M Wildrick; J T Wharton; M Blick
Journal:  Cancer Res       Date:  1990-05-01       Impact factor: 12.701

9.  Loss of heterozygosity and amplification on chromosome 11q in human ovarian cancer.

Authors:  W D Foulkes; I G Campbell; G W Stamp; J Trowsdale
Journal:  Br J Cancer       Date:  1993-02       Impact factor: 7.640

10.  Alteration of the p53 tumor suppressor gene occurs independently of K-ras activation and more frequently in serous adenocarcinomas than in other common epithelial tumors of the human ovary.

Authors:  M Fujita; T Enomoto; M Inoue; O Tanizawa; M Ozaki; J M Rice; T Nomura
Journal:  Jpn J Cancer Res       Date:  1994-12
View more
  1 in total

1.  Alterations of ATM and CADM1 in chromosomal 11q22.3-23.2 region are associated with the development of invasive cervical carcinoma.

Authors:  Dipanjana Mazumder Indra; Sraboni Mitra; Anup Roy; Ranajit Kumar Mondal; Partha Sarathi Basu; Susanta Roychoudhury; Runu Chakravarty; Chinmay Kumar Panda
Journal:  Hum Genet       Date:  2011-06-05       Impact factor: 4.132

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.